UCHL1作为预后因素,促进宫状状细胞癌的癌症干
Qingge Jia1, Hongjie Wang2, Xin Xiao2
1Department of Reproductive Endocrinology, Xi'an International Medical Center Hospital, Northwest University, Xi'an, China.
Pathology, research and practice
|May 31, 2023
概括
UCHL1是宫支状细胞癌 (CESC) 的预后因素. 它促进癌症的干细胞,扩散,迁移和入侵,为CESC治疗提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 子宫癌 (CESC) 的全球发病率和死亡率很高.
- 癌症干细胞 (CSC) 是CESC的一个有前途的治疗点.
- 在 CESC 中 UCHL1 的作用在很大程度上仍未被探索.
研究的目的:
- 研究UCHL1在CESC中的表达和功能.
- 确定UCHL1是否是CESC的预后因素.
- 探索UCHL1和CSC标记物之间的相关性.
主要方法:
- 在134名CESC患者的免疫组织化学.
- 对UCHL1和CSC标记物 (CD133,ABCG2,SOX2) 的TCGA数据库分析.
- 西部斑块,球形形成,CCK-8,划痕,穿孔和异种移植试验,以评估UCHL1的体外和体内功能.
主要成果:
- 在CESC瘤中,UCHL1表达升高,与较差的存活率相关.
- UCHL1的表达与CSC标记物有关,促进癌症干性.
- UCHL1过度表达增强了扩散,迁移和入侵;敲除抑制了这些过程.
结论:
- 在CESC中,UCHL1是显著的预后因素.
- 在CESC中,UCHL1驱动癌症干,扩散,迁移和入侵.
- UCHL1代表了新的CESC治疗的潜在治疗标.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K


